Cargando…
Pulmonary sarcoidosis-like reactions induced by sintilimab in esophageal cancer: A case report
Esophageal cancer is one of the deadliest cancers in the world, with high incidence and mortality rates ranking among the top ten in China. The efficacy of conventional treatments is limited and often accompanied by severe adverse reactions, which results in unsatisfactory outcomes. The mechanism of...
Autores principales: | Li, Haoqian, Mu, Fengchun, Zou, Bing, Wang, Linlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403023/ https://www.ncbi.nlm.nih.gov/pubmed/37543824 http://dx.doi.org/10.1097/MD.0000000000034432 |
Ejemplares similares
-
A rare presentation of Sintilimab-induced swelling along the vessels: Case report
por: Liu, Liqiong, et al.
Publicado: (2023) -
The efficacy and safety of sintilimab combined with chemotherapy as the first-line treatment for metastatic esophageal squamous cell carcinoma
por: Zhao, Zheng, et al.
Publicado: (2023) -
Immune checkpoint inhibitor sintilimab-induced lethal myocarditis overlapping with myasthenia gravis in thymoma patient: A case report
por: Wang, Chen, et al.
Publicado: (2023) -
A rapid response of lung squamous cell carcinoma following treatment with sintilimab combined with recombinant humane endostatin injection and nab-paclitaxel in an elderly patient: A case report
por: Fang, Yueyu, et al.
Publicado: (2021) -
Sarcoidosis mimicking metastatic progression of pancreatic neuroendocrine tumor: A case report
por: Lolli, Ivan, et al.
Publicado: (2017)